
Eversense 365
Prescription continuous glucose monitoring for adults 18+ with diabetes.
Upper-arm glucose biosensor pairs with a wellness app for adults who do not use insulin.
Manufacturer product imagery; shown for product identification.
An original synthesis of the linked evidence. SmartWearGuide has not hands-on tested this device.
Lingo is most interesting as a behaviour-feedback tool, not a diabetes-treatment replacement. The upper-arm sensor supplies frequent interstitial-glucose readings to a wellness app for adults who do not use insulin. That can make the relationship between a meal, a walk and the following glucose pattern easier to see without repeatedly taking individual measurements.
Abbott documents up to 14 days of wear and a 60-minute warm-up. Those details translate into a multi-day routine rather than an instant answer when the applicator is opened. The app's interpretation is part of the product, so the buying decision should include whether its coaching style is helpful and whether its data practices are acceptable to the user.
The purchase plan deserves as much attention as the app. The current shop distinguishes non-renewing short plans from an automatically renewing longer subscription. A short, purposeful trial may answer whether the feedback is useful before committing to repeated sensor wear and continuing payments.
Why #3 in this selectionThird for a distinct consumer wellness workflow. Stelo takes the earlier slot for its explicitly defined OTC audience; neither is ranked as a universal medical upgrade.
The compromiseRepeated sensors create a continuing cost and skin-contact commitment. A response to one meal is not a diagnosis or proof that a particular food is unhealthy.
[1] Buy Lingo CGM Biosensor & App | Lingo by Abbott [2] Abbott Lingo manufacturer image provenance
Manufacturer-based technical brief. No exact-model independent hands-on test verified for this entry; SmartWearGuide has not tested it.
Buy Lingo CGM Biosensor & App | Lingo by Abbott manufacturerRelease date not verified · Documented product in the stated source market; destination availability and checkout not tested.
Exact initial release date is not established in this review brief. Current catalogue status is Released; clinical eligibility and local access may differ.Abbott
Two-week plan: one 14-day biosensor
Official displayed price; shipping destination, tax treatment and checkout not tested.Check merchant offer ↗Price source ↗ Checked 2026-10-12Abbott
Four-week plan: two 14-day biosensors
Official displayed price; shipping destination, tax treatment and checkout not tested.Check merchant offer ↗Price source ↗ Checked 2026-10-12Abbott
12-week auto-renewing plan: six biosensors
Auto-renews at $249 every 12 weeks unless cancelled.Check merchant offer ↗Price source ↗ Checked 2026-10-12Official displayed price, original currency. See configuration and availability for the exact offer.
Official product documentation checked. Country-specific fulfilment and checkout were not tested.
Prices are snapshots, not a live stock feed. Taxes, shipping, prescription lenses and accessories can change the total.

Prescription continuous glucose monitoring for adults 18+ with diabetes.

Medical interstitial glucose monitoring for people age 2+ with diabetes, including pregnancy per UK labelling.

Prescription glucose sensor used with a compatible MiniMed 780G system.
Our first price observations were recorded 2026-10-12. A chart appears after a second observation of the same merchant, market and configuration.
Earlier prices are not available. New verified checks are collected by the cloud catalogue updater.
Follow this modelOwn it, tried it, or still deciding? Share what matters to you.
Start the conversation.
No comments yet. Your experience could help the next person choose.